Transcept Pharmaceuticals, Inc.
Company Information

Transcept Pharmaceuticals, Inc. Company Profile

Transcept Pharmaceuticals may not make a bitter pill easier to swallow, but it'll make the pill more effective once it's inside. The company's drug delivery technology enhances absorption rates of active drug agents, reducing absorption times, as well as the time it takes for the drug to take effect. Transcept targets medications where rapid absorption would significantly benefit treatment, including central nervous system and psychiatric disorders. Approved by the FDA in 2011 and launched in 2012, its first commercial product, Intermezzo, is a quick-acting, low-dosage medication for treating insomnia that occurs in the middle of the night. Transcept contracts with third parties for manufacturing and packaging.